PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery.
EFFICACY OF PERIARTICULAR VASOCONSTRICTOR INFILTRATION (PVI) VERSUS ERECTOR SPINAE PLANE BLOCK (ESP) IN REDUCING BLEEDING AND POSTOPERATIVE PAIN CONTROL IN LUMBAR FUSION SURGERY: RANDOMIZED CLINICAL TRIAL.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mireia MD, PhD Rodriguez Prieto, Anesthesiologist
- Phone Number: 677896054
- Email: mrodriguezpr@santpau.cat
Study Locations
-
-
Barcelona
-
Barcelona, Barcelona, Spain, 08025
- Recruiting
- Hospital de La Santa Creu i Sant Pau
-
Contact:
- Mireia Rodriguez Prieto, Anesthesiologist
- Phone Number: 677896054
- Email: mrodriguezpr@santpau.cat
-
-
Murcia
-
Murcia, Murcia, Spain, 30011
- Not yet recruiting
- Hospital Quiron Murcia
-
Contact:
- Vicente MD Roqués Escolar, Anesthesiologist
- Email: virroes@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- More than 18 years old.
- ASA I-III
- Scheduled primary spinal instrumentation surgery (lumbar/thoracolumbar fusion)
- Signed informed consent
Exclusion Criteria:
- Allergy/contraindication to study drugs (ropivacaine, epinephrine)
- Coagulopathy.
- Infection at block site
- Neuromuscular disease affecting evaluation.
- Chronic opioid use (>30mg morphine equivalents/day)
- Cognitive impairment preventing pain reporting.
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Arm 1: PVI (Periarticular Vasoconstrictor Infiltration)
Once patient is anesthetized and positioned prone for surgery: Ultrasound probe is placed in sagittal plane to identify sacrum and laminae.
Bilateral multilevel injections at instrumentation levels: retrolaminar space, thoracolumbar fascia, supraspinous ligament, and subcutaneous tissue at incision site.
After negative blood aspiration, 20mL of local anesthetic and epinephrine are injected using a volum of 20ml/vertebra in deep planes, plus 20-40mL in subcutaneous tissue (total volum administered: 150-200mL) bilateral according to instrumentation levels.
Multiple punctures required.
PVI block is Performed by trained anesthesiologists in ultrasound guided regional anesthesia.
|
Periarticular Vasoconstrictor Infiltration (PVI) vs ESP Block: Multi-level infiltration technique (4 planes: retrolaminar, thoracolumbar fascia, supraspinous ligament, subcutaneous) vs single interfascial injection.
High-volume (150-200mL bilateral, 20mL/vertebra) vs low-volume (40mL total).
Multiple punctures (4-6 levels) vs single-level per side.
Paravertebral chemical sympathectomy vs somatic nerve blockade.
Targets surgical field bleeding control + analgesia vs thoracic dermatomal analgesia only.
|
|
Active Comparator: Arm 2: Erector Spinae Plane Block (ESP)
Patient anesthetized and positioned prone: Ultrasound probe placed sagittal to identify sacrum/laminae, then shifted laterally to transverse processes.
SonoTAP 21G needle inserted cranio-caudal at instrumentation levels locating the tip above transverse process.
After negative blood aspiration, 20mL ropivacaine + epinephrine are injected interfascial between transverse process and erector spinae muscle.
Confirmed spread under ultrasound.
Bilateral administration.
Multiple punctures if needed.
Performed by trained anesthesiologists in reagional anesthesia.
|
Erector Spinae Plane Block (ESP) vs PVI Infiltration: Single interfascial injection vs multi-level infiltration.
Low-volume (20mL/side, 40mL total) vs high-volume (150-200mL).
Single puncture per side at transverse processes vs multiple punctures (4-6 levels).
Tip positioned above transverse process targeting erector spinae interfascial plane vs 4 anatomical planes (retrolaminar, fascia, ligament, subcutaneous).
Somatic nerve blockade (thoracic dermatomes) vs paravertebral chemical sympathectomy + analgesia.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Surgical Bleeding
Time Frame: Day 0
|
Total blood loss measured by aspiration from surgical field + weighed gauzes (after subtracting irrigation fluid volume)
|
Day 0
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Pain (NRS)
Time Frame: Day 1, day 2
|
Numeric Rating Scale (0-10) for pain intensity
|
Day 1, day 2
|
|
Opioid Consumption
Time Frame: Day 1, Day 2
|
Total morphine equivalents (rescue doses) in first 48h
|
Day 1, Day 2
|
|
Fromme Surgical Field Grade
Time Frame: Day 0
|
Surgical field bleeding quality (Grade 0-4)
|
Day 0
|
|
Length of Hospital Stay
Time Frame: Perioperative
|
Days from surgery to hospital discharge
|
Perioperative
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IBSP-IPV-2024-178
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.